Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Flagship Ventures Fund Iv, L.p.


  • Large Shareholder at Moderna Inc. (MRNA), 2019-12-12
  • Large Shareholder at Transmedics Group Inc. (TMDX), 2019-10-31
  • Large Shareholder at Axcella Health Inc. (AXLA), 2019-05-15
  • Large Shareholder at Kaleido Biosciences Inc. (KLDO), 2019-03-06
  • Large Shareholder at Rubius Therapeutics Inc. (RUBY), 2018-07-23
  • Large Shareholder at Evelo Biosciences Inc. (EVLO), 2018-05-16
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2017-08-21
  • Large Shareholder at Eleven Biotherapeutics Inc. (EBIO), 2016-09-26
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-15
  • Large Shareholder at Seres Therapeutics Inc. (MCRB), 2016-05-27
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2014-08-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SYRS $12.50 80,000 Large Shareholder 918,664 2016-07-06 Filing
SYRS $12.50 320,000 Large Shareholder 3,674,660 2016-07-06 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EBIO $3.10 10,293 Large Shareholder 106,787 2016-09-23 Filing
EBIO $3.10 41,178 Large Shareholder 426,885 2016-09-23 Filing
EBIO $3.16 3,118 Large Shareholder 117,080 2016-09-23 Filing
EBIO $3.16 12,482 Large Shareholder 468,063 2016-09-23 Filing
EBIO $3.17 47,090 Large Shareholder 120,198 2016-09-22 Filing